| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael P Marshal, Chad M Burton, Deena J Chisolm, Gina S Sucato, Mark S Friedma. Cross-sectional evidence for a stress-negative affect pathway to substance use among sexual minority girls. Clinical and translational science. vol 6. issue 4. 2014-04-23. PMID:23919370. |
four models were estimated to test mediated pathways from sexual orientation to gay-related victimization (mediator 1), to depression symptoms (mediator 2), and then to each of four substance use variables: cigarettes, marijuana, alcohol, and heavy alcohol use. |
2014-04-23 |
2023-08-12 |
Not clear |
| Petra Amchova, Jana Kucerova, Valentina Giugliano, Zuzana Babinska, Mary T Zanda, Maria Scherma, Ladislav Dusek, Paola Fadda, Vincenzo Micale, Alexandra Sulcova, Walter Fratta, Liana Fattor. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Frontiers in pharmacology. vol 5. 2014-04-01. PMID:24688470. |
depression has been associated with drug consumption, including heavy or problematic cannabis use. |
2014-04-01 |
2023-08-12 |
rat |
| Roy Otten, Rutger C M E Engel. Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addiction biology. vol 18. issue 5. 2014-03-10. PMID:21967091. |
evidence for the assumption that cannabis use is associated with depression and depressive symptoms is inconsistent and mostly weak. |
2014-03-10 |
2023-08-12 |
Not clear |
| Shira Sagie, Yehuda Eliasi, Ido Livneh, Yosi Bart, Einat Monovic. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness]. Harefuah. vol 152. issue 12. 2014-02-20. PMID:24483000. |
medicalization of marijuana encourages frequent use, which may elevate depression. |
2014-02-20 |
2023-08-12 |
Not clear |
| Jade M Franklin, Matt Mathew, Gonzalo A Carrasc. Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats. Neuroscience letters. vol 548. 2014-02-07. PMID:23721787. |
recent behavioral reports suggest that repeated exposure to cannabis and synthetic cannabinoid agonists is linked with mental disorders associated with dysfunction of serotonin 2a (5-ht2a) receptor neurotransmission such as anxiety and depression. |
2014-02-07 |
2023-08-12 |
rat |
| Elizabeth Osuch, Evelyn Vingilis, Erin Ross, Christeen Forster, Carolyn Summerhurs. Cannabis use, addiction risk and functional impairment in youth seeking treatment for primary mood or anxiety concerns. International journal of adolescent medicine and health. vol 25. issue 3. 2014-01-17. PMID:23839811. |
independently, functional impairment was predicted by inattentive coping style, depression severity, and total cannabis use score. |
2014-01-17 |
2023-08-12 |
human |
| Alline C Campos, Zaira Ortega, Javier Palazuelos, Manoela V Fogaça, Daniele C Aguiar, Javier Díaz-Alonso, Silvia Ortega-Gutiérrez, Henar Vázquez-Villa, Fabricio A Moreira, Manuel Guzmán, Ismael Galve-Roperh, Francisco S Guimarãe. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. The international journal of neuropsychopharmacology. vol 16. issue 6. 2014-01-15. PMID:23298518. |
cannabidiol (cbd), the main non-psychotomimetic component of the plant cannabis sativa, exerts therapeutically promising effects on human mental health such as inhibition of psychosis, anxiety and depression. |
2014-01-15 |
2023-08-12 |
mouse |
| Supa Pengpid, Karl Peltzer, Hendry van der Heever, Linda Skaa. Screening and brief interventions for hazardous and harmful alcohol use among university students in South Africa: results from a randomized controlled trial. International journal of environmental research and public health. vol 10. issue 5. 2013-11-25. PMID:23698697. |
further, the depression scores marginally significantly decreased over time across treatment groups, while other substance use (tobacco and cannabis use), self-rated health status and posttraumatic stress disorder (ptsd) scores did not change over time across treatment groups. |
2013-11-25 |
2023-08-12 |
Not clear |
| Kimberly A Babson, Matthew Tyler Boden, Marcel O Bonn-Mille. Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. The American journal of drug and alcohol abuse. vol 39. issue 3. 2013-10-17. PMID:23721537. |
sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. |
2013-10-17 |
2023-08-12 |
Not clear |
| Kimberly A Babson, Matthew Tyler Boden, Marcel O Bonn-Mille. Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. The American journal of drug and alcohol abuse. vol 39. issue 3. 2013-10-17. PMID:23721537. |
this study sought to extend research on the relation between depression symptoms and problematic cannabis use by evaluating the potential moderating role of perceived sleep quality among medical cannabis users. |
2013-10-17 |
2023-08-12 |
Not clear |
| Sarah Tosato, Antonio Lasalvia, Chiara Bonetto, Rodolfo Mazzoncini, Doriana Cristofalo, Katia De Santi, Mariaelena Bertani, Sarah Bissoli, Lorenza Lazzarotto, Giovanna Marrella, Dario Lamonaca, Rosanna Riolo, Francesco Gardellin, Anna Urbani, Michele Tansella, Mirella Rugger. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). Journal of psychiatric research. vol 47. issue 4. 2013-08-21. PMID:23290558. |
this study aimed in an fep sample to determine whether cannabis use is associated with (1) a higher level of positive symptoms, a lower level of depression and a better premorbid adjustment, (2) an earlier age of onset, and a better premorbid iq. |
2013-08-21 |
2023-08-12 |
human |
| Marina Goldman, Jesse J Suh, Kevin G Lynch, Regina Szucs, Jennifer Ross, Hu Xie, Charles P O'Brien, David W Osli. Identifying risk factors for marijuana use among veterans affairs patients. Journal of addiction medicine. vol 4. issue 1. 2013-07-04. PMID:21625378. |
if data commonly collected in the primary care setting (eg, use of alcohol, smoking status, and depression symptoms) could predict cannabis use, then providers can implement targeted marijuana screening in high-risk groups. |
2013-07-04 |
2023-08-12 |
Not clear |
| Gina M Najolia, Julia D Buckner, Alex S Cohe. Cannabis use and schizotypy: the role of social anxiety and other negative affective states. Psychiatry research. vol 200. issue 2-3. 2013-05-17. PMID:22920791. |
building on this research, we explored the impact of social anxiety, measured by the social interaction anxiety scale (sias), and depression and trait anxiety reported on the brief symptom inventory (bsi), on the relationship of schizotypy, measured by the schizotypy personality questionnaire-brief revised (spq-br), to cannabis use (n=220 schizotypy, 436 controls) and frequent use and cannabis-related problems among users (n=88 schizotypy, 83 controls) in college undergraduates. |
2013-05-17 |
2023-08-12 |
Not clear |
| Gina M Najolia, Julia D Buckner, Alex S Cohe. Cannabis use and schizotypy: the role of social anxiety and other negative affective states. Psychiatry research. vol 200. issue 2-3. 2013-05-17. PMID:22920791. |
depression and trait anxiety also moderated the relationship of schizotypy to frequent cannabis use and more cannabis-related problems, but results varied across high-positive, negative, and disorganized schizotypy subgroups. |
2013-05-17 |
2023-08-12 |
Not clear |
| Felecia N Jinwala, Mayank Gupt. Synthetic cannabis and respiratory depression. Journal of child and adolescent psychopharmacology. vol 22. issue 6. 2013-05-17. PMID:23234589. |
synthetic cannabis and respiratory depression. |
2013-05-17 |
2023-08-12 |
Not clear |
| Felecia N Jinwala, Mayank Gupt. Synthetic cannabis and respiratory depression. Journal of child and adolescent psychopharmacology. vol 22. issue 6. 2013-05-17. PMID:23234589. |
we are the first to report, to our knowledge, two cases of self-reported synthetic cannabis use leading to respiratory depression and necessary intubation. |
2013-05-17 |
2023-08-12 |
Not clear |
| L John Horwood, David M Fergusson, Carolyn Coffey, George C Patton, Robert Tait, Diana Smart, Primrose Letcher, Edmund Silins, Delyse M Hutchinso. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug and alcohol dependence. vol 126. issue 3. 2013-05-03. PMID:22749560. |
cannabis and depression: an integrative data analysis of four australasian cohorts. |
2013-05-03 |
2023-08-12 |
Not clear |
| David A Gilder, Cindy L Ehler. Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample. The American journal on addictions. vol 21. issue 6. 2013-04-16. PMID:23082832. |
depression symptoms associated with cannabis dependence in an adolescent american indian community sample. |
2013-04-16 |
2023-08-12 |
Not clear |
| David A Gilder, Cindy L Ehler. Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample. The American journal on addictions. vol 21. issue 6. 2013-04-16. PMID:23082832. |
depression and substance use disorders, including cannabis dependence, arise during adolescence, are frequently comorbid, and represent major health burdens in the general us population. |
2013-04-16 |
2023-08-12 |
Not clear |
| David A Gilder, Cindy L Ehler. Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample. The American journal on addictions. vol 21. issue 6. 2013-04-16. PMID:23082832. |
yet little is known about the association of depression symptoms with cannabis and other substance use and use disorders in native american adolescents. |
2013-04-16 |
2023-08-12 |
Not clear |